Enabling the eHealth Infrastructure - ICW Developer Conference

ICWThe 3rd ICW Developer Conference takes place in Wiesloch, Germany on May 5th 2009. This is the premier event to learn about ICW's eHealth technology platform approach. In sessions on ICW's Partner program, the Open eHealth Integration Platform, ICW eHealth Framework, and the ICW Software Development Kit, conference participants will learn how to integrate and develop health care applications with ICW's technology platform.

The ICW Developer Conference is free of charge and open to the public, but space is limited and is offered on a first-come, first-served basis.

Selected Sessions

ICW Partner Guides
This session provides an overview of what the ICW Partner Guides are and their benefits and shows how you can engage with ICW to build value-add applications.

DFB - Managing the Data for the German National Soccer Team with the eHF
In cooperation with DFBmedien ICW is currently extending the DFBnet, a web based application developed with the eHF that gives trainers and managers of the german soccer association secure access to sensitive data on all games and players.

The ICW Software Development Kit (SDK)
This session demonstrates the benefits of using the ICW SDK for creating, sending, and receiving data that is exchanged between source systems and the ICW system, such as an ePrescription or the medication information.

HealthCare Interoperability Standards
This session will highlight the latest developments in health IT standards around the world, what ICW has been doing in terms of adoption and contributions, and what ICW plans to do next with regards to providing developers and partners the tools they need to standardize their products.

For further information, full session details and registration, please visit:
http://idn.icw-global.com/conference

Related news articles:

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...

Oracle Purchase of Cerner Approved

Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital...